World-renowned industry analyst firm, Frost & Sullivan, has recognized BrightInsight with its 2020 Global Entrepreneurial Company of the Year Award for our work advancing and accelerating digital health innovation in biopharma and medtech.
Each year, Frost & Sullivan presents this award to the company that demonstrates excellence devising a strong growth strategy and robustly implementing it. The recipient must show strength in product and technology innovation, leadership in customer value, as well as speed in responding to market needs.
The Global Entrepreneurial Company of the Year Award looks at emerging market players and recognizes best practices that position the company for future growth excellence. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify industry best practices.
As Nitin Naik, vice president at Frost & Sullivan, notes
"BrightInsight provides a sustainable competitive advantage, strengthening the software-as-a-service (SaaS) model and its status as the leading global regulated IoT solution provider. Overall, it is well positioned to capture significant market share in this fast-growing segment."
Using a SaaS infrastructure, our BrightInsight Platform is flexible, fast, and secure, offering end-to-end data management, hosting and integration that dramatically reduces risks and costs while ensuring compliance at each step along the way.
With significant adoption by leading, innovative biopharma and medtech companies including CSL Behring, Novo Nordisk and Roche, the BrightInsight Platform is quickly becoming the market standard for accelerating regulated digital health innovation. BrightInsight is motivated every day to partner with our customers to enable them to improve patient outcomes with cutting edge digital health solutions built on our security-, privacy- and regulatory-compliant platform.
Read the full Frost & Sullivan report here.
This latest award comes closely on the heels of other industry recognitions, including ranking 13th on LinkedIn’s Top 2020 Startups and being named to the 2020 CB Insights Digital Health 150. We look forward to keeping you updated on more news as we move into Q4.